AVX adds medical device development facility to headquarters

Share

AVXAVX Corp., a maker and supplier of passive components and interconnect solutions, recently announced that it has added a new medical device development facility to its corporate headquarters, located in Fountain Inn, S.C.

The new facility, announced April 18, has more than 2,500 square ft of cleanrooms and support space for device fabrication, biological analysis and electrical testing equipment. AVX says the lab will provide space for 8 to 10 researchers involved in medical device component development.

“Backed by more than 20 years’ experience providing advanced passive component and interconnect solutions to the medical industry, our new medical device development facility represents an investment of more than $2.1 million and demonstrates our continued commitment to developing state-of-the-art component solutions for life-saving and life-enhancing technologies,” John Lawing, CTO and vice president of R&D at AVX, said in a news release.

“Our medical design engineers have an innovative approach to problem-solving and an in-depth understanding of medical device design requirements, and our quality systems lead the industry and support customer-specific change control, documentation, specification, and testing procedures,” Lawing said.

AVX’s offerings include advanced tantalum and ceramic capacitors, thin film products, connectors, EMI filters and feedthroughs, SAW filters and timing devices. The components go in a range of medical devices. Medtech companies have used AVX components in Class III implantable and life-support devices including pacemakers, ICDs and neuromodulation devices. They’ve also gone into Class I and II devices including cochlear implants, insulin pumps, drug pumps, hearing aids, heart monitors, vascular assist devices, MRI and X-ray machines, external defibrillators, and other monitoring and diagnostic devices.

AVX Corporation has 20 manufacturing and warehouse facilities in 11 countries around the world.

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

Speak Your Mind

*